tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adverum Biotechnologies price target lowered to $5.50 from $12 at Mizuho
PremiumThe FlyAdverum Biotechnologies price target lowered to $5.50 from $12 at Mizuho
2M ago
Adverum Biotechnologies price target raised to $4 from $3 at RBC Capital
Premium
The Fly
Adverum Biotechnologies price target raised to $4 from $3 at RBC Capital
2M ago
Adverum Biotechnologies’ Phase 3 Study on Ixo-vec: A Potential Game-Changer for AMD Treatment
Premium
Company Announcements
Adverum Biotechnologies’ Phase 3 Study on Ixo-vec: A Potential Game-Changer for AMD Treatment
2M ago
Adverum Biotechnologies Announces Merger with Eli Lilly
PremiumCompany AnnouncementsAdverum Biotechnologies Announces Merger with Eli Lilly
2M ago
Adverum Biotechnologies trading resumes
Premium
The Fly
Adverum Biotechnologies trading resumes
2M ago
Eli Lilly to acquire Adverum Biotechnologies for up to $12.47 per share
Premium
The Fly
Eli Lilly to acquire Adverum Biotechnologies for up to $12.47 per share
2M ago
Buy Rating for Adverum Biotechnologies: Promising Phase 3 Trial Progress and Financial Resilience
PremiumRatingsBuy Rating for Adverum Biotechnologies: Promising Phase 3 Trial Progress and Financial Resilience
3M ago
Adverum Biotechnologies Completes Screening for Phase 3 Trial
Premium
Company Announcements
Adverum Biotechnologies Completes Screening for Phase 3 Trial
3M ago
Adverum reports completion of screening for Phase 3 ARTEMIS trial
Premium
The Fly
Adverum reports completion of screening for Phase 3 ARTEMIS trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100